Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal Protein L21 Pseudogene 28, denoted as RPL21P28, is a pseudogene related to ribosomal protein L21, which is a structural component of the 60S subunit of the eukaryotic ribosome. Pseudogenes are inactive genes that have lost their function due to mutations or other genetic changes. They do not encode functional proteins but can sometimes influence gene expression or be involved in regulatory processes[3][7]. This pseudogene does not actively participate in protein synthesis or other biological processes typically associated with ribosomal proteins, but it can provide insights into genetic evolution and regulation.
Not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal Protein L21 Pseudogene 28 (RPL21P28).